Europe Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023

List of Tables

The Europe Arthritic Therapeutic Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,462.7 Million by 2030. The UK market is exhibiting a CAGR of 3.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.5% during (2023 - 2030).

Patient preferences, beliefs, and experiences play a significant role in shaping their adoption. Factors such as treatment efficacy, route of administration, frequency of dosing, potential side effects, and cost impact patients' willingness to adhere to prescribed therapies. Establishing collaborative treatment plans that align with patient's values, preferences, and lifestyle factors promotes shared decision-making between healthcare providers and patients.

Arthritic therapeutics are primarily utilized to manage the symptoms associated with arthritis, including pain, inflammation, stiffness, and swelling. Pharmacological interventions such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, analgesics, and disease-modifying antirheumatic drugs (DMARDs) help alleviate pain and reduce inflammation, improving mobility and enhancing the quality of life for patients with arthritis.

The aging population in Europe is accompanied by increased healthcare expenditure, as older adults require more medical services, treatments, and long-term care for chronic conditions, including arthritis. The aging population in Europe fuels demand for senior care services, specialized clinics, and multidisciplinary care teams focused on managing age-related health conditions, including arthritis. Thus, all these factors will uplift the regional market's expansion in the coming years.

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

AbbVie, Inc.
Pfizer, Inc.
Amgen, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd.
Viatris, Inc.
Bausch Health Companies, Inc.
Sanofi S.A.
Merck & Co., Inc.
Bristol-Myers Squibb Company

Europe Arthritic Therapeutic Market Report Segmentation

By Application

Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Others

By Product Type

Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Disease Modified Anti-rheumatoid Drugs (DMARDs)
Biologics
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Europe Arthritic Therapeutic Market, by Application
- 1.4.2Europe Arthritic Therapeutic Market, by Product Type
- 1.4.3Europe Arthritic Therapeutic Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5.Europe Arthritic Therapeutic Market, by Application

5.1Europe Rheumatoid Arthritis Market, by Country
5.2Europe Psoriatic Arthritis Market, by Country
5.3Europe Osteoarthritis Market, by Country
5.4Europe Ankylosing Spondylitis Market, by Country
5.5Europe Others Market, by Country

Chapter 6.Europe Arthritic Therapeutic Market, by Product Type

6.1Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3Europe Biologics Market, by Country
6.4Europe Others Market, by Country

Chapter 7.Europe Arthritic Therapeutic Market, by Country

7.1Germany Arthritic Therapeutic Market
- 7.1.1Germany Arthritic Therapeutic Market, by Application
- 7.1.2Germany Arthritic Therapeutic Market, by Product Type
7.2UK Arthritic Therapeutic Market
- 7.2.1UK Arthritic Therapeutic Market, by Application
- 7.2.2UK Arthritic Therapeutic Market, by Product Type
7.3France Arthritic Therapeutic Market
- 7.3.1France Arthritic Therapeutic Market, by Application
- 7.3.2France Arthritic Therapeutic Market, by Product Type
7.4Russia Arthritic Therapeutic Market
- 7.4.1Russia Arthritic Therapeutic Market, by Application
- 7.4.2Russia Arthritic Therapeutic Market, by Product Type
7.5Spain Arthritic Therapeutic Market
- 7.5.1Spain Arthritic Therapeutic Market, by Application
- 7.5.2Spain Arthritic Therapeutic Market, by Product Type
7.6Italy Arthritic Therapeutic Market
- 7.6.1Italy Arthritic Therapeutic Market, by Application
- 7.6.2Italy Arthritic Therapeutic Market, by Product Type
7.7Rest of Europe Arthritic Therapeutic Market
- 7.7.1Rest of Europe Arthritic Therapeutic Market, by Application
- 7.7.2Rest of Europe Arthritic Therapeutic Market, by Product Type

Chapter 8.Company Profiles

8.1AbbVie, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Acquisition and Mergers:
- 8.2.6SWOT Analysis
8.3Amgen, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Acquisition and Mergers:
- 8.3.6SWOT Analysis
8.4Novartis AG
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Trials and Approvals:
- 8.4.6SWOT Analysis
8.5F. Hoffmann-La Roche Ltd.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
8.6Viatris, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Trials and Approvals:
- 8.6.6SWOT Analysis
8.7Bausch Health Companies, Inc
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Sanofi S.A.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5Recent strategies and developments:
  - 8.8.5.1Partnerships, Collaborations, and Agreements:
- 8.8.6SWOT Analysis
8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
  - 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
8.10.Bristol-Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

LIST OF TABLES

TABLE 1Europe Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2Europe Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3Europe Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4Europe Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5Europe Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6Europe Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7Europe Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8Europe Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9Europe Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10Europe Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11Europe Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12Europe Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 14Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 15Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16Europe Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21Europe Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22Europe Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 24Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 25Europe Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26Europe Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27Germany Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28Germany Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29Germany Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30Germany Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31Germany Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32Germany Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33UK Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34UK Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35UK Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36UK Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37UK Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38UK Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39France Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40France Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41France Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42France Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43France Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44France Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45Russia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46Russia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47Russia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48Russia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49Russia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50Russia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51Spain Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 52Spain Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 53Spain Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 54Spain Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 55Spain Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 56Spain Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 57Italy Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 58Italy Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 59Italy Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 60Italy Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 61Italy Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 62Italy Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 63Rest of Europe Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 64Rest of Europe Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 65Rest of Europe Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 66Rest of Europe Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 67Rest of Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 68Rest of Europe Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 69Key information - AbbVie, Inc.
TABLE 70Key Information - Pfizer, Inc.
TABLE 71Key Information - Amgen, Inc.
TABLE 72Key Information - Novartis AG
TABLE 73Key Information - F. Hoffmann-La Roche Ltd.
TABLE 74Key Information - Viatris, Inc.
TABLE 75key information - Bausch Health Companies, Inc.
TABLE 76Key Information - Sanofi S.A.
TABLE 77Key Information - Merck & Co., Inc.
TABLE 78Key Information - Bristol-Myers Squibb Company

Europe Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents